XML 22 R121.htm IDEA: XBRL DOCUMENT v2.4.0.6
Schedule II Valuation And Qualifying Accounts (Details) (USD $)
3 Months Ended 12 Months Ended
Dec. 31, 2010
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Valuation and Qualifying Accounts Disclosure [Line Items]        
Deferred Other Tax Expense Benefit       $ (335,300,000)
Allowance For Billed Receivables [Member]
       
Valuation and Qualifying Accounts Disclosure [Line Items]        
Balance at Beginning of Period   223,000   3,682,000
Charged to Costs and Expenses   (223,000) [1]    
Deductions From Reserves       (3,459,000) [2]
Balance at End of Period 223,000     223,000
Inventory Allowance [Member]
       
Valuation and Qualifying Accounts Disclosure [Line Items]        
Balance at Beginning of Period   31,360,000 31,370,000 28,297,000
Charged to Costs and Expenses   (31,360,000) [1] (10,000) [1] 4,297,000 [1]
Deductions From Reserves       (1,224,000) [2]
Balance at End of Period 31,370,000   31,360,000 31,370,000
Deferred Tax Valuation Allowance [Member]
       
Valuation and Qualifying Accounts Disclosure [Line Items]        
Balance at Beginning of Period   10,887,000 11,229,000 414,038,000
Charged to Costs and Expenses   (3,779,000) [1] (375,000) [1] (402,809,000) [1]
Charged to Other Accounts     33,000 [3]  
Balance at End of Period 11,229,000 7,108,000 10,887,000 11,229,000
Deferred Other Tax Expense Benefit 335,300,000      
Valuation allowance change 67,500,000      
Continuing Operations [Member]
       
Valuation and Qualifying Accounts Disclosure [Line Items]        
Valuation allowance change       40,100,000
Discontinued Operations [Member]
       
Valuation and Qualifying Accounts Disclosure [Line Items]        
Valuation allowance change       $ 27,400,000
[1] During the fourth quarter of 2010, we determined, based on all available evidence, that a full valuation allowance was no longer required on our deferred tax assets and, therefore, $335.3 million of the valuation allowance was reversed as an income tax benefit. In addition, the valuation allowance was reduced by $67.5 million, of which $40.1 million was recorded as a benefit to continuing operations and $27.4 million was recorded as a benefit to discontinued operations. Allowances for billed receivables and inventory charged to costs and expenses in 2012 reflect the Sale of SS/L on November 2, 2012.
[2] Deductions from reserves reflect write-offs of uncollectible billed receivables and disposals of inventory.
[3] Changes in the deferred tax valuation allowance which have been charged to other accounts have been recorded in accumulated other comprehensive loss and other deferred tax assets.